Moderna Inc (MRNA)
54.63
+0.27
(+0.50%)
USD |
NASDAQ |
Nov 01, 16:00
55.00
+0.37
(+0.68%)
After-Hours: 20:00
Moderna Price to Book Value: 1.793 for Nov. 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 1.793 |
| October 31, 2024 | 1.784 |
| October 30, 2024 | 1.796 |
| October 29, 2024 | 1.812 |
| October 28, 2024 | 1.799 |
| October 25, 2024 | 1.742 |
| October 24, 2024 | 1.733 |
| October 23, 2024 | 1.752 |
| October 22, 2024 | 1.753 |
| October 21, 2024 | 1.766 |
| October 18, 2024 | 1.776 |
| October 17, 2024 | 1.799 |
| October 16, 2024 | 1.886 |
| October 15, 2024 | 1.881 |
| October 14, 2024 | 1.895 |
| October 11, 2024 | 1.913 |
| October 10, 2024 | 1.865 |
| October 09, 2024 | 1.932 |
| October 08, 2024 | 1.916 |
| October 07, 2024 | 1.927 |
| October 04, 2024 | 1.976 |
| October 03, 2024 | 2.004 |
| October 02, 2024 | 2.073 |
| October 01, 2024 | 2.098 |
| September 30, 2024 | 2.193 |
| Date | Value |
|---|---|
| September 27, 2024 | 2.158 |
| September 26, 2024 | 2.098 |
| September 25, 2024 | 2.089 |
| September 24, 2024 | 2.099 |
| September 23, 2024 | 2.105 |
| September 20, 2024 | 2.156 |
| September 19, 2024 | 2.232 |
| September 18, 2024 | 2.293 |
| September 17, 2024 | 2.363 |
| September 16, 2024 | 2.270 |
| September 13, 2024 | 2.241 |
| September 12, 2024 | 2.287 |
| September 11, 2024 | 2.610 |
| September 10, 2024 | 2.602 |
| September 09, 2024 | 2.514 |
| September 06, 2024 | 2.392 |
| September 05, 2024 | 2.410 |
| September 04, 2024 | 2.379 |
| September 03, 2024 | 2.394 |
| August 30, 2024 | 2.540 |
| August 29, 2024 | 2.547 |
| August 28, 2024 | 2.572 |
| August 27, 2024 | 2.592 |
| August 26, 2024 | 2.680 |
| August 23, 2024 | 2.706 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.733
Minimum
Oct 24 2024
29.17
Maximum
Aug 09 2021
7.863
Average
4.100
Median
Price to Book Value Benchmarks
| Eli Lilly and Co | 54.59 |
| Merck & Co Inc | 5.926 |
| Pfizer Inc | 1.815 |
| Novavax Inc | -- |
| Amgen Inc | 22.80 |
Price to Book Value Related Metrics
| PS Ratio | 4.186 |
| Price | 54.63 |
| Earnings Yield | -28.15% |
| Market Cap | 21.00B |